Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: a case report by Lakshmanagowda, Preethi Bangalore et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Cases Journal
Open Access Case Report
Abscopal effect in a patient with chronic lymphocytic leukemia 
during radiation therapy: a case report
Preethi Bangalore Lakshmanagowda*1, Lokesh Viswanath2, 
Naveen Thimmaiah2, Lokanath Dasappa3, Sanjay Sudakar Supe4 and 
Pramod Kallur2
Address: 1Department of Physiology, M.S. Ramaiah Medical College, Bangalore, India, 2Department of Radiation Oncology, Kidwai Memorial 
Institute of Oncology, Bangalore, India, 3Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India and 
4Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, India
Email: Preethi Bangalore Lakshmanagowda* - blpreethi97@gmail.com; Lokesh Viswanath - lokpreeth@hotmail.com; 
Naveen Thimmaiah - drnaveenradon@yahoo.com; Lokanath Dasappa - drloku@yahoo.com; Sanjay Sudakar Supe - sanjayssupe@yahoo.com; 
Pramod Kallur - drkprpraod@gmail.com
* Corresponding author    
Abstract
Radiotherapy has a significant impact on the local tumor environment and its distant component.
Abscopal effect is the bystander effect of radiotherapy observed at a site distant to that irradiated
within the same subject. Abscopal effect even though described, is not a common clinical event.
We report a documented observation of abscopal effect in a patient of Chronic Lymphocytic
Leukemia during radiation therapy.
Introduction
The Abscopal effect is the effect of radiation therapy some-
times observed as response of tumour masses remote
from the site of irradiation [1]. The term "abscopal effect"
caused by radiotherapy was first coined by Mole in 1953
[2]. The word abscopal is derived from Latin ab means
"position away from" and scopos meaning "a target for
shooting at."
Much of the observed physiological Abscopal effect has
been associated with splenic irradiaition[1]. Abscopal
effect even though described, is not a common clinical
event after radiotherapy, there have been reports of such
effects in variety of malignancies including lymphoma,
papillary adenocarcinoma, melanoma, adenocarcinoma
of the esophagus, chronic lymphocytic leukemia, and
hepatocellular carcinoma [3-10].
Case presentation
A 65 year old female patient, a known case of Chronic
Lymphocytic Leukemia since two years, presented to us
with a massive right axillary lymphadenopathy with
severe pain and neurovascular pressure effects in the
axilla.
This patient at diagnosis, about two years back had pre-
sented with Right Axillay lymphadenopathy (approx 6-8
cms, Multiple) and was initially treated with chemother-
apy COPP (cyclophosphamide, vincristine, procarbazine,
prednisone) regimen for 3 cycles and then switched over
to Chlorambucil & prednisone. Since she had disease pro-
gression in spite of active treatment all Chemotherapy
drugs were stopped two months prior to presentation
with us and symptomatic care with analgesics instituted.
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On examination the patient had a massive right axillary
lymphadenopathy, with multiple matted lymph nodes.
The biggest node measured 14 × 12 × 10 cms with other
axillary nodes ranging from 5 to 4 cms. She also had mul-
tiple (>1 cms) bilateral cervical lymphnodes (the largest 2
× 2 cms) at presentation were located in the right level II
neck region away from the field of radiotherapy. She had
no generalized lymphadenopathy or splenomegaly.
The patient was treated with local field Radiation therapy
to axilla with anterior & posterior parallel opposed local
fields, to a dose of 2400 cGy in 12 fractions, 5 fractions per
week (Figure 1).
One week after radiotherapy the lymphnodes in the neck
which was unirradiated, and away from the field of radio-
therapy, started regressing and by the end of two weeks of
radiotherapy the lymphnodes in the neck had shown
complete regression due to abscopal effect and the axillary
node had a partial response with subjective improvement
in symptoms and performance status (Figure 2). 6 months
after radiation therapy the patient continues to have sus-
tained palliation in the irradiatied and distant site.
Discussion & Conclusion
Radiotherapy has a significant impact on the local micro-
environment of tissues within the radiation portal. Cells
treated with Ionizing radiation sustain damage to its
nuclear & cytoplasmic components, inducing of apopto-
sis, up-regulation transcription factors. Resulting in
increased vascular permeability, altered cytokine levels
and local inflammation [11,12].
Radiotherapy to one cell has direct impact on an adjacent
cell resulting in bystander effect [13,14]. There have been
two main theories proposed to explain the abscopal anti-
tumor effect. The first applies to leukemias and lympho-
mas, it is hypothesized that during splenic irradiation
diseased lymphocytes circulate through the irradiated vol-
ume (spleen), as the splenic size decreases the remotely
located masses also decrease in size, giving an impression
of a systemic antitumor effect from local treatment
[1,4,5]. The second applies to solid tumors, it is postu-
lated that local radiation induces a release of mitotic
inhibitors (cytokines) into the circulation that mediate a
systemic antitumor effect. It has been demonstrated that
an elevation of circulating tumor necrosis factor after radi-
otherapy that coincided with the regression of a hepato-
cellular carcinoma situated away from the radiation field
[2,10].
Others proposed hypothesis is that the abscopal effect is
mediated by the immune system. Irradiation of tumour in
one site induces release of circulating tumor antigen or
inflammatory factors that may then mediate an aug-
mented immune response against unirradiated, malig-
nant lesions expressing similar tumor antigens. It has
been shown that local radiotherapy increases the activity
of natural killer cells [15,16].
In our patient by virtue of this unusual presentation, we
were able to predict and observe the rare abscopal effect in
the site distant from the site of irradiation. Irradiation of
the disease in the axilla resulted in tumor mass regression
in untreated distant site.
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Massive Axillary Lymphnode is marked in dotted line, 
the radiotherapy field is shaped like a rectangle and 
one of the multiple bilateral neck lymphnode (2 × 2 
cms) away from the radiotherapy field is marked as 
small circle in the neck.
the irradiatied axillary lymph node shows greater than 50%  response at the end of radiotherapy and the unirridiated neck  node away from the site of radiation has completely disap- peared due to Abscopal effect Figure 2
the irradiatied axillary lymph node shows greater 
than 50% response at the end of radiotherapy and the 
unirridiated neck node away from the site of radia-
tion has completely disappeared due to Abscopal 
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